
Unlike in humans, most of the implants are understood to remain in the body perpetually as animals have ephemeral life. These excerpts are according to the report titled, "Veterinary Orthopedic Implant Market—Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018-2026," which has been added to the ever-expanding repository of Market Research Hub (MRH). Growing number of pet ownership and pet population are being observed in the recent past. According to the American Pet Products Association (APPA), US households owned more than 94 million cats in 2017, while dog population neared 90 million in the same year. After decades of painstaking research and clinical testing, bioabsorbable implants are gradually being used in a number of human orthopedic procedures. That said, almost all veterinary orthopedic implants are manufactured using titanium or titanium-based alloys, stainless steel. Recently, bioabsorbable implants have gained traction for use in veterinary patients. The bioabsorbable implants introduced in the veterinary industry are presently being used in tibial tuberosity advancement (TTA) procedures. This surgical procedure is able to treat cranial cruciate ligament (CrCL) deficient stifle joints. Rising incidence of traffic accidents, animal fights are also known to foster the veterinary orthopedic implant market. North America is set to grab a bigger share of pie apropos with respect to market share, attributed mainly to soaring pet expenditure and rising pet adoption. Meanwhile, with soaring number of veterinarians and surging research and development cost, Europe will hold considerable share during the assessment period. Asia Pacific is projected to grow at an average pace, while MEA and Latin America will observed a stable growth.